Inventor · disambiguated record
Peter Turecek
Also filed as: TURECEK PETER · TURECEK PETER L · TURECEK PETER LEOPOLD
118 granted patents·52 pending applications·1,535 citations·filing 1993–2025
99Inventor score
Top patents by PatentIndex Score
170 records- 0197US11020458B2Factor VIII polymer conjugatesBAXALTA INC·Filed 2019·Granted Jun 1, 2021·9 cites·1 claims
- 0297US10758599B2Stabilized liquid and lyophilized ADAMTS13 formulationsBAXALTA INC·Filed 2019·Granted Sep 1, 2020·10 cites·28 claims
- 0397US7645860B2Factor VIII polymer conjugatesBAXTER HEALTHCARE SA·Filed 2008·Granted Jan 12, 2010·36 cites·10 claims
- 0497US6224862B1Pharmaceutical preparation for treating blood coagulation disordersBAXTER AG·Filed 2000·Granted May 1, 2001·88 cites·4 claims
- 0596US5883078AHemostyptic and tissue adhesiveIMMUNO AG·Filed 1996·Granted Mar 16, 1999·164 cites·35 claims
- 0694US11191837B2Recombinant VWF formulationsTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Dec 7, 2021·9 cites·12 claims
- 0794US8623612B2Method for testing treatment of ADAMTS13 deficiencyBAXTER INT·Filed 2013·Granted Jan 7, 2014·10 cites·21 claims
- 0894US8546096B2Method for identifying a non-anticoagulant sulfated polysaccharide which enhances blood coagulation dependence on FXIDOCKAL MICHAEL·Filed 2009·Granted Oct 1, 2013·14 cites·14 claims
- 0994US2025099559A1Stabilized liquid and lyophilized adamts13 formulationsTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 1093US11197916B2Lyophilized recombinant VWF formulationsBAXALTA INC·Filed 2019·Granted Dec 14, 2021·9 cites·15 claims
- 1193US9731024B2Nucleophilic catalysts for oxime linkageBAXALTA INC·Filed 2014·Granted Aug 15, 2017·9 cites·15 claims
- 1293US9110085B2Methods of testing effectiveness of a treatment for thromobotic thrombocytopenic purpura by measuring ADAMTS13-mediated in vivo cleavage of von Willebrand factorBAXTER INT·Filed 2013·Granted Aug 18, 2015·8 cites·17 claims
- 1393US7884075B2Polymer-factor VIII-von Willebrand factor-conjugatesBAXTER INT·Filed 2005·Granted Feb 8, 2011·18 cites·85 claims
- 1492US10209263B2Methods of measuring adamts 13 activityBAXALTA INC·Filed 2016·Granted Feb 19, 2019·5 cites·32 claims
- 1592US7683158B2Pegylated factor VIIIBAXTER INT·Filed 2007·Granted Mar 23, 2010·16 cites·9 claims
- 1691US10238720B2Stabilized liquid and lyophilized ADAMTS13 formulationsBAXALTA INC·Filed 2018·Granted Mar 26, 2019·5 cites·30 claims
- 1791US8809501B2Nucleophilic catalysts for oxime linkageSIEKMANN JUERGEN·Filed 2012·Granted Aug 19, 2014·7 cites·34 claims
- 1891US8623352B2Stabilized liquid and lyophilized ADAMTS13 formulationsMATTHIESSEN PETER·Filed 2010·Granted Jan 7, 2014·13 cites·50 claims
- 1991US8173597B2Modified recombinant factor VIII and von Willebrand factor and methods of useSCHWARZ HANS-PETER·Filed 2008·Granted May 8, 2012·9 cites·15 claims
- 2091US7501117B2Composition exhibiting a von Willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLVBAXTER INNOVATIONS GMBH·Filed 2005·Granted Mar 10, 2009·12 cites·8 claims
- 2191US6926894B2Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLVBAXTER AG·Filed 2001·Granted Aug 9, 2005·39 cites·27 claims
- 2291US5891843APharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its useIMMUNO AKTIENGESLLSCHAFT·Filed 1996·Granted Apr 6, 1999·83 cites·13 claims
- 2390US10576160B2Nucleophilic catalysts for oxime linkageBAXALTA INC·Filed 2017·Granted Mar 3, 2020·3 cites·15 claims
- 2490US8642737B2Nucleophilic catalysts for oxime linkageSIEKMANN JUERGEN·Filed 2011·Granted Feb 4, 2014·12 cites·66 claims
- 2590US6919311B2Factor VII polypeptide having factor VII:C activitySANQUIN BLOEDVOORZIENING·Filed 2001·Granted Jul 19, 2005·33 cites·8 claims
- 2690US5866122APharmaceutical preparation for treating blood coagulation disordersIMMUNO AG·Filed 1997·Granted Feb 2, 1999·59 cites·45 claims
- 2789US10414793B2Nucleophilic catalysts for oxime linkageBAXALTA INC·Filed 2016·Granted Sep 17, 2019·4 cites·52 claims
- 2889US9937244B2Stabilized liquid and lyophilized ADAMTS13 formulationsBAXALTA INC·Filed 2017·Granted Apr 10, 2018·4 cites·32 claims
- 2989US9572778B2Stabilized liquid and lyophilized ADAMTS13 formulationsBAXALTA INC·Filed 2016·Granted Feb 21, 2017·4 cites·54 claims
- 3089US9492555B2Nucleophilic catalysts for oxime linkageBAXALTA INC·Filed 2013·Granted Nov 15, 2016·7 cites·7 claims
- 3189US8357779B2Polymer-von Willebrand factor-conjugatesBAXTER INT·Filed 2011·Granted Jan 22, 2013·9 cites·51 claims
- 3289US6013620APharmaceutical composition for the treatment of blood coagulation diseases, methods for the production thereof and its useBAXTER AG·Filed 1997·Granted Jan 11, 2000·79 cites·25 claims
- 3388US10232022B2Lyophilized recombinant VWF formulationsBAXALTA INC·Filed 2015·Granted Mar 19, 2019·9 cites·16 claims
- 3488US9488651B2Methods of measuring ADAMTS 13 activityBAXALTA INC·Filed 2014·Granted Nov 8, 2016·3 cites·18 claims
- 3588US6017891AStable preparation for the treatment of blood coagulation disordersBAXTER AG·Filed 1997·Granted Jan 25, 2000·78 cites·27 claims
- 3687US12178861B2Stabilized liquid and lyophilized ADAMTS13 formulationsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Dec 31, 2024·0 cites·20 claims
- 3787US8637640B2Blood coagulation protein conjugatesSIEKMANN JUERGEN·Filed 2010·Granted Jan 28, 2014·9 cites·9 claims
- 3887US7985838B2Factor VIII polymer conjugatesBAXTER INT·Filed 2010·Granted Jul 26, 2011·5 cites·20 claims
- 3987US7700551B2Hydrolysable polymeric FMOC-linkerBAXTER INT·Filed 2008·Granted Apr 20, 2010·3 cites·9 claims
- 4087US5854403AMethod for isolation of highly pure von Willebrand FactorIMMUNO AG·Filed 1996·Granted Dec 29, 1998·53 cites·16 claims
- 4187US2024335549A1Therapeutic proteins with increased half-life and methods of preparing sameBAXALTA INC·Filed 2024·Application pending·0 cites
- 4286US8945897B2Materials and methods for conjugating a water soluble fatty acid derivative to a proteinSIEKMANN JUERGEN·Filed 2011·Granted Feb 3, 2015·15 cites·37 claims
- 4386US8415114B2Methods of measuring ADAMTS13-mediated in vivo cleavage of von Willebrand factor and uses thereofVARADI KATALIN·Filed 2009·Granted Apr 9, 2013·8 cites·18 claims
- 4485US10350301B2Blood coagulation protein conjugatesBAXALTA INC·Filed 2016·Granted Jul 16, 2019·4 cites·35 claims
- 4585US8377375B2Methods for the inactivation of microorganisms in biological fluids, flow through reactors and methods of controlling the light sum dose to effectively inactivate microorganisms in batch reactorsBAXTER INT·Filed 2011·Granted Feb 19, 2013·7 cites·24 claims
- 4684US8835388B2Polymer von Willebrand factor-conjugatesBAXTER INT·Filed 2012·Granted Sep 16, 2014·9 cites·20 claims
- 4783US8114633B2Methods for differentiating plasma-derived protein from recombinant protein in a sampleWEBER ALFRED·Filed 2008·Granted Feb 14, 2012·7 cites·17 claims
- 4882US11040109B2Blood coagulation protein conjugatesBAXALTA INC·Filed 2019·Granted Jun 22, 2021·1 cites·29 claims
- 4982US7993580B2Methods for the inactivation of microorganisms in biological fluids, flow through reactors and methods of controlling the light sum dose to effectively inactivate microorganisms in batch reactorsBAXTER INT·Filed 2004·Granted Aug 9, 2011·32 cites·23 claims
- 5082US7985839B2Factor VIII polymer conjugatesBAXTER INT·Filed 2010·Granted Jul 26, 2011·5 cites·22 claims
Showing the top 50 of 170 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Peter Turecek files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →